SC
TDOC icon

Swan Capital’s Teladoc Health TDOC Stock Holding History

Swan Capital’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68 Hold
8
– – ﹤0.01% 569
2026
Q1 		$44 Hold
8
– – ﹤0.01% 539
2025
Q4 		$56 Hold
8
– – ﹤0.01% 500
2025
Q3 		$62 Hold
8
– – ﹤0.01% 479
2025
Q2 		$70 Hold
8
– – ﹤0.01% 463
2025
Q1 		$64 Hold
8
– – ﹤0.01% 365
2024
Q4 		$73 Hold
8
– – ﹤0.01% 363
2024
Q3 		$73 Hold
8
– – ﹤0.01% 332
2024
Q2 		$78 Buy
+8
New +$98 ﹤0.01% 293

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Swan Capital's TDOC Position: Q2 2026 in Review

Swan Capital held its Teladoc Health (TDOC) position steady in Q2 2026 at 8 shares worth $68. The position accounts for ﹤0.01% of the portfolio, ranked #569.

Swan Capital first reported a position in TDOC in Q2 2024 and has held it in 9 quarters since. The position peaked at $78 in Q2 2024. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Swan Capital held 8 shares of Teladoc Health worth $68 as of Q2 2026.
  • Swan Capital left its Teladoc Health share count unchanged in Q2 2026.
  • Teladoc Health made up ﹤0.01% of Swan Capital's portfolio in Q2 2026, its #569 holding.
  • Swan Capital first reported a position in Teladoc Health in Q2 2024 and has held it in 9 quarters since.
  • Swan Capital's Teladoc Health position peaked at $78 in Q2 2024.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Swan Capital's 13F filing for Q2 2026, filed 13 Aug 2026.